ArticleOncoimmunology2025

Dual nanobody-redirected and Bi-specific CD13/TIM3 CAR T cells eliminate AML xenografts without toxicity to human HSCs.

Xuyao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.